IMT Header

Short Courses*

Tuesday, August 25

Targeting the Cancer Mutanome 


Background and Update on Current Science

Laszlo Radvanyi, Ph.D., CSO, Lion Biotechnologies

Identification of Cancer Neo-Antigens and Potential Clinical Applications

Lelia Delamarre, Ph.D., Scientific Manager, Cancer Immunology, Genentech

Identifying Suitable Neoepitopes – Seeing through the Fog of Suppression

Pramod Srivastava, M.D., Ph.D., Professor, Immunology and Medicine, University of Connecticut School of Medicine; Director, Carole and Ray Neag Comprehensive Cancer Center

What T Cells See on Human Cancer

Marit van Buuren, MSc, Ph.D. Student, Cancer Immunology, Netherlands Cancer Institute

*Separate registration is required.